OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

New and Emerging Oral/Topical Small-Molecule Treatments for Psoriasis
Elena Carmona‐Rocha, Lluís Rusiñol, L. Puig
Pharmaceutics (2024) Vol. 16, Iss. 2, pp. 239-239
Open Access | Times Cited: 13

Showing 13 citing articles:

Inhibition of the JAK-STAT Pathway in the Treatment of Psoriasis: A Review of the Literature
Andreea Roxana Furtunescu, Simona Roxana Georgescu, Mircea Tampa, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 4681-4681
Open Access | Times Cited: 7

Innovative Approaches to Psoriasis: Small Molecules Targeting Key Signaling Pathways
Meeral Gosia, Gaurav Doshi, Siddhi Parab, et al.
Immunological Investigations (2025), pp. 1-37
Closed Access

Landscape of anti-IL-23 therapy in inflammatory bowel disease: recent advances
Michael Colwill, Jennifer Clough, Samantha Baillie, et al.
Frontline Gastroenterology (2025), pp. flgastro-102830
Closed Access

The Role of Aryl Hydrocarbon Receptor in Skin Homeostasis: Implications for Therapeutic Strategies in Skin Disorders
Jundan Yang, Pei Qiao, Gang Wang, et al.
Cell Biochemistry and Function (2025) Vol. 43, Iss. 2
Open Access

Targeting IL‐23 with Small Molecule Inhibitors: A New Horizon In Psoriasis Therapy
Raghad Sharbaji, Pınar Si̇yah
ChemistrySelect (2025) Vol. 10, Iss. 8
Closed Access

RORγt inhibitors in clinical development for the treatment of autoimmune diseases: challenges and opportunities
Nannan Sun, Yonghui Wang
Expert Opinion on Therapeutic Patents (2025)
Closed Access

Naturally derived bioactive compounds as precision modulators of immune and inflammatory mechanisms in psoriatic conditions
Andrei-Flavius Radu, Delia Mirela Ţiţ, Laura Endres, et al.
Inflammopharmacology (2024)
Open Access | Times Cited: 3

New and emerging oral therapies for psoriasis
Orhan Yılmaz, João Pedro Pinto, Tiago Torres
Drugs in Context (2024) Vol. 13, pp. 1-24
Open Access | Times Cited: 2

Targeted siRNA Therapy for Psoriasis: Translating Preclinical Potential into Clinical Treatments
Fuyu Zhao, Jianan Zhao, Kai Wei, et al.
ImmunoTargets and Therapy (2024) Vol. Volume 13, pp. 259-271
Open Access | Times Cited: 2

Treatment of chronic plaque psoriasis: An overview on current update
Priyanka Jurel, Shiv Bahadur, Meenakshi Bajpai
Deleted Journal (2024) Vol. 2, pp. 100004-100004
Closed Access | Times Cited: 1

Design, Synthesis, and Biological Evaluation of New Selective PDE4 Inhibitors for Topical Treatment of Psoriasis
Dengqin He, Gang Li, Jia‐Qiang Wu, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 22, pp. 20353-20371
Closed Access | Times Cited: 1

Small Molecules in the Management of Psoriasis and Psoriatic Arthritis
Venkata Chalam Konakanchi, Bikash Ranjan Kar, Dharshini Sathishkumar, et al.
Indian Journal of Dermatology (2024) Vol. 69, Iss. 3, pp. 249-255
Open Access

Novel pharmacotherapies and breakthroughs in psoriasis treatment: 2024 and beyond
Antonio Portarapillo, Luca Potestio, Nello Tommasino, et al.
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 9, pp. 1187-1198
Closed Access

Th Pathways in Immune-Mediated Skin Disorders: A Guide for Strategic Treatment Decisions
Reinhart Speeckaert, Arno Belpaire, Jo Lambert, et al.
Immune Network (2024) Vol. 24, Iss. 5
Open Access

Page 1

Scroll to top